Pfizer (PFE) Financials
Pfizer (PFE) Historical Financial Statements and Key Metrics for 1990 - 2020
Full Pfizer financials for 1990 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Pfizer Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2020-Sep-27 | 12,131 | 9,602 (79.2 %) | 3,328 (17.9 %) | 2,194 (18.1 %) | 4,864 | 0.39 |
| 2020-Jun-28 | 11,801 | 9,569 (81.1 %) | 3,441 (29.2 %) | 3,426 (29.0 %) | 5,568 | 0.61 |
| 2020-Mar-29 | 12,028 | 9,682 (80.5 %) | 4,588 (38.1 %) | 3,401 (28.3 %) | 4,391 | 0.61 |
| 2019-Dec-31 | 12,688 | 10,092 (79.5 %) | -3,844 (-30.3 %) | -336 (-2.6 %) | 604 | -0.06 |
| 2019-Sep-29 | 12,680 | 10,225 (80.6 %) | 11,113 (87.6 %) | 7,680 (60.6 %) | 12,688 | 1.36 |
| 2019-Jun-30 | 13,264 | 10,714 (80.8 %) | 4,430 (33.4 %) | 5,046 (38.0 %) | 6,048 | 0.89 |
| 2019-Mar-31 | 13,118 | 10,707 (81.6 %) | 4,625 (35.3 %) | 3,884 (29.6 %) | 6,223 | 0.68 |
Full historical income statements for 1990 - 2020 is included in the
US Historical Financials dataset.
Pfizer Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2020-Sep-27 | 178,983 | 113,488 | 61,528 | 65,259 | 10,499 |
| 2020-Jun-28 | 177,934 | 113,598 | 63,613 | 64,336 | 11,382 |
| 2020-Mar-29 | 166,336 | 101,310 | 52,288 | 65,026 | 10,350 |
| 2019-Dec-31 | 167,489 | 104,345 | 52,150 | 63,144 | 9,830 |
| 2019-Sep-29 | 170,446 | 105,343 | 52,661 | 65,103 | 9,087 |
| 2019-Jun-30 | 156,199 | 96,632 | 46,675 | 59,567 | 12,912 |
| 2019-Mar-31 | 155,421 | 96,615 | 45,143 | 58,806 | 11,619 |
Full historical balance sheet data for 1990 - 2020 is included in the
US Historical Financials dataset.
Pfizer Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2020-Sep-27 | 2,090 | 0 | 0 | 1,560 |
| 2020-Jun-28 | 3,556 | -13,011 | 9,159 | 3,076 |
| 2020-Mar-29 | 3,132 | -71 | -2,200 | 2,637 |
| 2019-Dec-31 | 3,769 | -2,833 | -2,440 | 3,043 |
| 2019-Sep-29 | 4,508 | -6,760 | 3,273 | 3,846 |
| 2019-Jun-30 | 2,613 | -1,902 | -851 | 2,025 |
| 2019-Mar-31 | 1,697 | 7,550 | -8,467 | 1,079 |
Full historical cash flow data for 1990 - 2020 is included in the
US Historical Financials dataset.
Pfizer Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2020-Sep-27 | 191,859 | 247,348 | 15.82 | 87.45 | 2.94 |
| 2020-Jun-28 | 181,629 | 241,960 | 15.39 | 53.01 | 2.82 |
| 2020-Mar-29 | 179,810 | 229,610 | 14.95 | 52.87 | 2.77 |
| 2019-Dec-31 | 212,965 | 262,348 | 16.78 | -633.82 | 3.37 |
| 2019-Sep-29 | 195,123 | 242,568 | 15.39 | 25.41 | 3.00 |
| 2019-Jun-30 | 236,454 | 279,206 | 17.83 | 46.86 | 3.97 |
| 2019-Mar-31 | 232,550 | 271,285 | 17.73 | 59.87 | 3.95 |
Full historical valuation and operating metrics for 1990 - 2020 are included in the
US Historical Financials dataset.